New Journey Health Technology Group Co.,LTD (SHE:002219)

China flag China · Delayed Price · Currency is CNY
2.340
+0.030 (1.30%)
Apr 29, 2026, 3:04 PM CST
7.34%
Market Cap 7.95B
Revenue (ttm) 2.98B
Net Income (ttm) 25.76M
Shares Out 3.44B
EPS (ttm) 0.01
PE Ratio 296.04
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 86,175,330
Average Volume 119,277,110
Open 2.330
Previous Close 2.310
Day's Range 2.290 - 2.350
52-Week Range 2.030 - 2.970
Beta 0.52
RSI 47.26
Earnings Date Apr 22, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other pro... [Read more]

Sector Healthcare
Founded 2001
Employees 9,097
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002219
Full Company Profile

Financial Performance

In 2025, SHE:002219's revenue was 3.05 billion, a decrease of -19.64% compared to the previous year's 3.80 billion. Earnings were 30.94 million, a decrease of -73.04%.

Financial Statements

News

There is no news available yet.